Post Profile

Old drug may have new tricks for fighting cancer

(Arizona State University) Results show that the drug ibrutinib acts as a potent kinase inhibitor for ERBB4, limits growth in human cancer cells in the laboratory, and reduces tumor size in mice. The sensitivity of ERBB4 to ibrutinib is similar to that of BTK, the original target of the drug.
read more


Related Posts

Why some tumors withstand treatment

Academics / General Science : ScienceDaily: Science Society

Researchers have uncovered a mechanism that allows cancer cells to evade targeted therapies. The study reveals why a certain class of drugs, known as kinase inhibitors, doesn't always halt tumor growth. The researchers found that wh...

Study Finds Potential to Match Tumors with Known Cancer Drugs

Health : Newswise Medical News

Researchers have found a new way to match potential cancer treatments with an individual tumor: assess the landscape of kinases and find a kinase inhibitor that goes after the highest-expressing kinases in that tumor.

Why can't mTOR inhibitors kill cancer? Study explains

Health : EurekAlert: Health

(University of Texas Health Science Center at San Antonio) Anti-cancer drugs called mTOR inhibitors slow the growth of cancer cells but show limited ability to cause cancer cell death. New studies explain why.

Possible Personalized Brain Tumor Therapy With Src Inhibitors Following Discovery That Metabolic Protein Plays Role In Tumor Cell Formation And Growth

Health : Medical News Today

The embryonic enzyme pyruvate kinase M2 (PKM2) has a well-established role in metabolism and is highly expressed in human cancers. Now, a team led by researchers at the University of Texas MD Anderson Cancer Center reports in advanc...

Cisplatin-Resistant Cancer Cells Sensitive To Experimental Anticancer Drugs Called PARP Inhibitors

Health : Medical News Today

Cisplatin-resistant non-small cell lung cancer cells expressed high levels of hyperactivated PARP1. Cells succumbed to PARP inhibitors in vitro. PARP inhibitor slowed cisplatin-resistant tumor growth in mice. Poly (ADP-ribose) polym...


Copyright © 2016 Regator, LLC